EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Whole Exome Sequencing in Children With Type 1 Diabetes Before Age 6 Years Reveals Insights Into Disease Heterogeneity

Andreia Fiúza Ribeiro iD, Ana Laura Fitas iD, Marcela Oliveira Pires, Paula Matoso, Dário Ligeiro, Daniel Sobral, Carlos Penha-Gonçalves, Jocelyne Demengeot, Íris Caramalho iD, Catarina Limbert iD

Journal of Diabetes Research · 2024

DOI: 10.1155/2024/3076895 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Research, 2024. Verfasst von Andreia Fiúza Ribeiro und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Endocrinology Unit Hospital de Dona Estefânia São José Local Health Unit, Lisbon, Portugal. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Exome Sequencing, Genetic Predisposition to Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia, European Foundation for the Study of Diabetes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study is aimed at comparing whole exome sequencing (WES) data with the clinical presentation in children with type 1 diabetes onset ≤ 5 years of age (EOT1D).

Methods

WES was performed in 99 unrelated children with EOT1D with subsequent analysis to identify potentially deleterious rare variants in MODY genes. High‐resolution HLA class II haplotyping, SNP genotyping, and T1D‐genetic risk score (T1D‐GRS) were also evaluated.

Results

Eight of the ninety‐nine EOT1D participants carried a potentially deleterious rare variant in a MODY gene. Rare variants affected five genes: GCK ( n = 1), HNF1B ( n = 2), HNF4A ( n = 1), PDX1 ( n = 2), and RFX6 ( n = 2). At diagnosis, these children had a mean age of 3.0 years, a mean HbA1c of 10.5%, a detectable C‐peptide in 5/8, and a positive islet autoantibody in 6/7. Children with MODY variants tend to exhibit a lower number of pancreatic autoantibodies and a lower fasting C‐peptide compared to EOT1D without MODY rare variants. They also carried at least one high‐risk DR3‐DQ2 or DR4‐DQ8 haplotype and exhibited a T1D‐GRS similar to the other individuals in the EOT1D cohort, but higher than healthy controls.

Conclusions

WES found potentially deleterious rare variants in MODY genes in 8.1% of EOT1D, occurring in the context of a T1D genetic background. Such genetic variants may contribute to disease precipitation by a β ‐cell dysfunction mechanism. This supports the concept of different endotypes of T1D, and WES at T1D onset may be a prerequisite for the implementation of precision therapies in children with autoimmune diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Exome SequencingGenetic Predisposition to DiseaseHumansChild, PreschoolFemaleMaleHepatocyte Nuclear Factor 1-betaTrans-ActivatorsHomeodomain ProteinsHepatocyte Nuclear Factor 4Germinal Center KinasesPolymorphism, Single NucleotideInfantC-PeptideAutoantibodiesChildHaplotypesDiabetes Mellitus, Type 2GlucokinaseRegulatory Factor X Transcription Factors

Stichwörter der Autor:innen

MODYearly-onsettype 1 diabeteswhole exome sequencingβ-cell dysfunction

Substanzen

pancreatic and duodenal homeobox 1 proteinHNF1B protein, humanRfx6 protein, humanHepatocyte Nuclear Factor 1-betaTrans-ActivatorsHNF4A protein, humanHomeodomain ProteinsHepatocyte Nuclear Factor 4Germinal Center KinasesMAP4K2 protein, human

Autor:innen und Institutionen

  • Pediatric Endocrinology Unit Hospital de Dona Estefânia São José Local Health Unit, Lisbon, Portugal.
  • Pediatric Department Hospital Prof. Doutor Fernando Fonseca Amadora Sintra Local Health Unit, Amadora, Portugal.
  • Comprehensive Health Research Centre (CHRC) NOVA Medical School Universidade NOVA de Lisboa, Lisbon, Portugal.
  • Pediatric Department Hospital de São Francisco Xavier Lisboa Ocidental Local Health Unit, Lisbon, Portugal.
  • Instituto Gulbenkian de Ciência, Oeiras, Portugal.
  • Blood and Transplantation Center of Lisbon Instituto Português do Sangue e da Transplantação, Lisbon, Portugal.

ORCID-Profile: Andreia Fiúza Ribeiro, Ana Laura Fitas, Íris Caramalho, Catarina Limbert

Förderung

  • Fundação para a Ciência e a Tecnologia
  • European Foundation for the Study of Diabetes

Zitieren

APA

Ribeiro, A. F., Fitas, A. L., Pires, M. O., Matoso, P., Ligeiro, D., Sobral, D., Penha-Gonçalves, C., Demengeot, J., Caramalho, Í., & Limbert, C. (2024). Whole Exome Sequencing in Children With Type 1 Diabetes Before Age 6 Years Reveals Insights Into Disease Heterogeneity. Journal of Diabetes Research. https://doi.org/10.1155/2024/3076895

Vancouver

Ribeiro AF, Fitas AL, Pires MO, Matoso P, Ligeiro D, Sobral D, et al. Whole Exome Sequencing in Children With Type 1 Diabetes Before Age 6 Years Reveals Insights Into Disease Heterogeneity. Journal of Diabetes Research. 2024. doi:10.1155/2024/3076895

BibTeX
@article{Ribeiro2024,
  author = {Ribeiro, Andreia Fiúza and Fitas, Ana Laura and Pires, Marcela Oliveira and Matoso, Paula and Ligeiro, Dário and Sobral, Daniel and Penha-Gonçalves, Carlos and Demengeot, Jocelyne and Caramalho, Íris and Limbert, Catarina},
  title = {Whole Exome Sequencing in Children With Type 1 Diabetes Before Age 6 Years Reveals Insights Into Disease Heterogeneity},
  journal = {Journal of Diabetes Research},
  year = {2024},
  doi = {10.1155/2024/3076895}
}
Kostenlos starten →